Skip to main content
Janiine Babcock, MD, Pediatric Hematology & Oncology, Seattle, WA, Seattle Children's Hospital


Pediatric Hematology & Oncology Seattle, WA

Attending Physician, W. Reed National Military Medical Center

Dr. Babcock is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Babcock's full profile

Already have an account?


  • I completed a rich and rewarding, 29 year career as a physician in the US Army and then joined the Cancer and Blood Disorders Center at Seattle Childrens where I work as inpatient Hematologist/Oncologist. I love caring for our patients and their families and could not be happier working with an incredible team at Seattle Childrens. Its an amazing collaborative, supportive, and stimulating environment.

Education & Training

  • Walter Reed Army Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1992
  • Tripler Army Medical Center
    Tripler Army Medical CenterResidency, Pediatrics, 1984 - 1987
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1984

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2013 - 2022
  • MD State Medical License
    MD State Medical License 2012 - 2022
  • DC State Medical License
    DC State Medical License 1994 - 2022
  • HI State Medical License
    HI State Medical License 1986 - 2014
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations


Journal Articles

  • Rapid card-based systems for blood product testing  
    Babcock JG, Holcomb JB, Hess JR, Infusion
  • Rodenticide-induced coagulopathy in a young child: A case of Munchausen syndrome by proxy  
    Babcock J, Pedersen A, Murphy M, Harnman K, Alving B., American Journal of Pediatric Hematology/Oncology


  • Kinetics of the Anti-PA Antibody Response to Reduced Schedules of Anthrax Vaccine Adsorbed in Humans
    C.L. Sabourin, N.A. Niemuth, H.J. Mayfield, T.L. Rudge, V.A. Semenova, H. Li, J. Schiffer, S. Parker, J. Babcock, W. Keitel, G. Poland, H. Keyserling, B.D. Plikaytis,..., Fifth International Anthrax Meeting, BACT
  • Anthrax Vaccine Adsorbed (BioThraxTM): A Human Reactogenicity and Immunogenicity Clinical Trial
    Marano N, Plikaytis B, Martin S, McNeil M, Stamper J, Di Pietra J, Quinn C, Babcock J, Keitel W, Keyserling H, Mulligan M, Poland G, Perkins B, Fifth International Anthrax Meeting, Nice, France
  • The recovery and survival of autologous human red cells exposed to 25°C for 24 hours
    Reid T, Babcock JG, Derse-Anthony CP, Hill HR, Posey LM, Boyce N, Lippert LE, Hess JR, Uniformed Services University for the Health Sciences Symposium, Bethesda, MD
  • Join now to see all

Grant Support

  • Anthrax Vaccine Research ProgramCenters for Disease Control and Prevention2001–2008
  • Development of the Leukotrap® RC AS-24 System and Leukotrap® Whole Blood Filter SystemMedsep Corp1995–1996


  • Chair, W. Reed Army Inst of Research Scientific Review Committee 2007 - 2009
  • Member and Senior Subject Matter Expert, Human Subjects Research Review Board for the Surgeon General, US Army 2003 - 2008

Research History

  • Collection of Blood Components from Healthy Donors for In Vitro ResearchPrincipal Investigator and Author. Approved November, 2001. Implemented January, 2002. Completed 2007. Associate Investigator 2006 to 2007.2002 - 2007
  • Maintenance of Performance and Alertness with Caffeine across Three Nights of Total Sleep DeprivationAssociate Investigator. Conducted July to September 2005.2005 - 2005
  • Anthrax Vaccine Adsorbed Microarray Response StudyAssociate Investigator2003 - 2004
  • Phase I safety and immunogenicity testing of Group B Meningococcal OMP-dLOS vaccines in healthy volunteersPrincipal Investigator2000 - 2001
  • Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli (ETEC) Vaccine Consisting of Heat-labile Toxin of E. coli (LT) and CS6 Colonization Factor Administered TranscutaneouslySub-investigator2000 - 2000
  • Evaluation of in Vivo Viability of Red Cells Stored for Prolonged Periods in the Leukotrap® RC AS-24 SystemAuthor and PI until August, 96. Co-investigator until completion in April, 1997.1996 - 1997
  • Type Protocol for Measuring the Recovery and Survival of Autologous Human Erythrocytes In VivoPI and Author1995 - 1996
  • Phlebotomy Procedures for Use on Human SubjectsPI and Author1994 - 1996

Professional Memberships

  • Public Responsibility in Medicine and Research
  • American Society of Pediatric Hematology and Oncology

Hospital Affiliations